miércoles, 3 de julio de 2024

FDA approves treatment for adults with Alzheimer’s disease Kisunla (donanemab-azbt)

https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-treatment-adults-alzheimers-disease?utm_medium=email&utm_source=govdelivery

No hay comentarios: